Clinical Trials Browser

INDUSTRY × Interventional × Colitis × Clear all

NCT01369329 2016-12-07

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Phase 3 Completed

769 enrolled 13 charts

Colitis, Crohn Disease, Inflammatory Bowel Diseases

NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Phase 2 Completed

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer